Cardiovascular technology provider Maquet Cardiovascular and its parent Getinge Group have inked a definitive agreement to acquire medical device technology developer Atrium Medical for $680 million.
Atrium products are used in interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and general surgery. The acquisition will strategically augment Maquet's existing therapy offerings, according to the vendor.
Atrium will operate as an independent, self-contained business unit of Maquet and will be led by Atrium's current president, Trevor Carlton. The deal is expected to close in the fourth quarter, subject to U.S. Federal Trade Commission (FTC) approval.
